Valuation: Sartorius AG

Market Cap 15.67B 17.57B 14.6B 13.29B 25.02B 1,692B 25.21B 176B 68.64B 864B 65.95B 64.53B 2,776B P/E 2026 *
66.3x
P/E 2027 * 50.9x
Enterprise Value 19.25B 21.58B 17.93B 16.32B 30.73B 2,078B 30.96B 217B 84.3B 1,061B 80.99B 79.25B 3,409B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.64x
Free-Float
35.87%
Yield 2026 *
0.32%
Yield 2027 * 0.39%
1 week-1.94%
Current month-1.70%
1 month+4.71%
3 months+5.47%
6 months+19.82%
Current year+6.02%
1 week 196.8
Extreme 196.8
212
1 month 180.6
Extreme 180.6
213.5
3 years 143
Extreme 143
290
5 years 143
Extreme 143
625
10 years 66.77
Extreme 66.772
843
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 70 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-18
Director/Board Member 77 2011-11-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-1.94%+15.06%-19.80% 17.65B
+2.65%-1.00%+23.51%+34.90% 242B
+3.18%-2.86%+4.31%+1.82% 150B
+3.44%-2.24%-9.83%+39.78% 138B
-0.34%-3.62%-56.03%-17.73% 61.74B
+2.51%+0.58%+14.07%+20.96% 49.08B
-1.08%-3.15%-22.50%-21.55% 47.43B
+2.07%-2.43%+20.72%+54.92% 47.3B
+1.96%-0.60%-7.17%+38.17% 44.25B
+3.05%-1.03%+33.81%+64.81% 41.78B
Average +1.94%-2.50%+1.59%+19.63% 91.4B
Weighted average by Cap. +2.36%-2.98%+4.15%+23.55%

Financials

2026 *2027 *
Net sales 3.72B 4.17B 3.47B 3.16B 5.94B 402B 5.99B 41.91B 16.3B 205B 15.66B 15.33B 659B 4.09B 4.58B 3.81B 3.46B 6.52B 441B 6.57B 46B 17.9B 225B 17.19B 16.82B 724B
Net income 255M 286M 238M 216M 408M 27.56B 411M 2.87B 1.12B 14.07B 1.07B 1.05B 45.21B 329M 369M 307M 279M 526M 35.55B 530M 3.71B 1.44B 18.15B 1.39B 1.36B 58.33B
Net Debt 3.58B 4.01B 3.33B 3.03B 5.71B 386B 5.75B 40.25B 15.66B 197B 15.04B 14.72B 633B 3.27B 3.67B 3.05B 2.77B 5.22B 353B 5.26B 36.81B 14.32B 180B 13.76B 13.46B 579B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
-
Date Price Change
26-10-05 €201.50 -0.49%
26-10-02 €202.50 +1.76%
26-10-01 €199.00 -3.40%
26-09-30 €206.00 -0.24%
26-09-29 €206.50 -0.72%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
251.40EUR
Average target price
273.63EUR
Spread / Average Target
+8.84%

Quarterly revenue - Rate of surprise